![Steven Avruch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Avruch
Direktor/Vorstandsmitglied bei Boston Center for the Arts
Vermögen: 32 593 $ am 31.05.2024
Profil
Steven N.
Avruch is currently the Director at the Boston Center for the Arts.
Previously, he served as the Chief Counsel, VP & Assistant Secretary at Biogen, Inc. from 2015 to 2017.
He also held the position of Secretary & Chief Legal Officer at AVROBIO, Inc. from 2020 to 2024.
Mr. Avruch completed his undergraduate degree at Dartmouth College and his graduate degree at Boston College Law School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
0,05% | 05.02.2024 | 22 022 ( 0,05% ) | 32 593 $ | 31.05.2024 |
Aktive Positionen von Steven Avruch
Unternehmen | Position | Beginn |
---|---|---|
Boston Center for the Arts | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Steven Avruch
Unternehmen | Position | Ende |
---|---|---|
TECTONIC THERAPEUTIC, INC. | General Counsel | 20.06.2024 |
BIOGEN INC. | General Counsel | 01.12.2017 |
Ausbildung von Steven Avruch
Boston College Law School | Graduate Degree |
Dartmouth College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Boston Center for the Arts |